Endometrioid Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Endometrioid Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) [Phase 3]
Phase 3 clinical trial evaluating Olvi-Vec in combination with platinum-doublet chemotherapy and Bevacizumab versus physician's choice of ch…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 trial evaluating the combination of Cirtuvivint and Olaparib for BRCA/Homologous Recombination Deficiency–related platinum-resistant…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. [Phase 2]
A Phase 2 clinical study of TORL-1-23 is evaluating its activity in platinum-resistant ovarian cancer. The trial is currently recruiting acr…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers [Phase 1]
This document reports a Phase 1 clinical trial of NI-1801 for mesothelin-expressing solid cancers, with recruiting status and multiple indic…